Palbociclib plus endocrine therapy in HR+/HER2- Advanced Breast Cancer patients: Interim Results of the PERFORM study

10. November 2023

Radosa J., Fietz T., Wilke J., Decker T., Petersen V., Deryal M., Knoblich J., Losem C., Rhein U., Schöttker B., Wrobel D., Pfeiler G., Zanucco E., Buncke J., Frank M., Woerner S.M., Gratzke, K., Adams, A., Glastetter E., Bartsch R., Lux M.P.

Download